Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW01329Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9

✓ Valid for 2027

Short description: Introduce Talquetamab in Subcu, Perc, New Tech 9

Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW01329

XW01329 is the ICD-10-PCS code for a introduction procedure on the subcutaneous tissue using a percutaneous approach with talquetamab antineoplastic (qualifier: new technology group 9). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

With a different device, use XW013L9 (paclitaxel-coated balloon technology, four or more balloons) and XW013S9 (iobenguane I-131 antineoplastic).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2024, effective October 1, 2023.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
1Subcutaneous Tissue
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
2Talquetamab Antineoplastic

Includes: TALVEY(tm)

7. Qualifier
9New Technology Group 9

Other versions of this procedure

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2024 (effective 10/1/2023): Added
  • No changes since FY2024.

Common questions about XW01329

Is XW01329 a valid ICD-10-PCS code for 2027?

Yes. XW01329 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.